BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30206138)

  • 41. Targeted treatment for sonic hedgehog-dependent medulloblastoma.
    Kieran MW
    Neuro Oncol; 2014 Aug; 16(8):1037-47. PubMed ID: 24951114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.
    Fernandez-L A; Northcott PA; Dalton J; Fraga C; Ellison D; Angers S; Taylor MD; Kenney AM
    Genes Dev; 2009 Dec; 23(23):2729-41. PubMed ID: 19952108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma.
    De Smaele E; Fragomeli C; Ferretti E; Pelloni M; Po A; Canettieri G; Coni S; Di Marcotullio L; Greco A; Moretti M; Di Rocco C; Pazzaglia S; Maroder M; Screpanti I; Giannini G; Gulino A
    Neoplasia; 2008 Jan; 10(1):89-98. PubMed ID: 18231642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repurposing the antihelmintic mebendazole as a hedgehog inhibitor.
    Larsen AR; Bai RY; Chung JH; Borodovsky A; Rudin CM; Riggins GJ; Bunz F
    Mol Cancer Ther; 2015 Jan; 14(1):3-13. PubMed ID: 25376612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice.
    Rao G; Pedone CA; Del Valle L; Reiss K; Holland EC; Fults DW
    Oncogene; 2004 Aug; 23(36):6156-62. PubMed ID: 15195141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
    Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
    Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma.
    Hayden Gephart MG; Su YS; Bandara S; Tsai FC; Hong J; Conley N; Rayburn H; Milenkovic L; Meyer T; Scott MP
    J Neurooncol; 2013 Nov; 115(2):161-8. PubMed ID: 24026530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.
    Zhu D; Osuka S; Zhang Z; Reichert ZR; Yang L; Kanemura Y; Jiang Y; You S; Zhang H; Devi NS; Bhattacharya D; Takano S; Gillespie GY; Macdonald T; Tan C; Nishikawa R; Nelson WG; Olson JJ; Van Meir EG
    Cancer Cell; 2018 Jun; 33(6):1004-1016.e5. PubMed ID: 29894688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway.
    Dhanyamraju PK; Holz PS; Finkernagel F; Fendrich V; Lauth M
    Mol Cancer Ther; 2015 Mar; 14(3):727-39. PubMed ID: 25552369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
    Kahn SA; Wang X; Nitta RT; Gholamin S; Theruvath J; Hutter G; Azad TD; Wadi L; Bolin S; Ramaswamy V; Esparza R; Liu KW; Edwards M; Swartling FJ; Sahoo D; Li G; Wechsler-Reya RJ; Reimand J; Cho YJ; Taylor MD; Weissman IL; Mitra SS; Cheshier SH
    Nat Commun; 2018 Oct; 9(1):4121. PubMed ID: 30297829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma.
    De Smaele E; Di Marcotullio L; Moretti M; Pelloni M; Occhione MA; Infante P; Cucchi D; Greco A; Pietrosanti L; Todorovic J; Coni S; Canettieri G; Ferretti E; Bei R; Maroder M; Screpanti I; Gulino A
    Neoplasia; 2011 Apr; 13(4):374-85. PubMed ID: 21472142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
    Hwang GH; Pazyra-Murphy MF; Seo HS; Dhe-Paganon S; Stopka SA; DiPiazza M; Sutter N; Gero TW; Volkert A; Ombelets L; Dittemore G; Rees MG; Ronan MM; Roth JA; Agar NYR; Scott DA; Segal RA
    Cancer Res; 2024 Mar; 84(6):872-886. PubMed ID: 38486486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
    Kim J; Lee JJ; Kim J; Gardner D; Beachy PA
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13432-7. PubMed ID: 20624968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis.
    Zhou H; Wang YX; Wu M; Lan X; Xiang D; Cai R; Ma Q; Miao J; Fang X; Wang J; Luo D; He Z; Cui Y; Liang P; Wang Y; Bian XW
    J Pathol; 2024 Apr; 262(4):427-440. PubMed ID: 38229567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
    Markant SL; Esparza LA; Sun J; Barton KL; McCoig LM; Grant GA; Crawford JR; Levy ML; Northcott PA; Shih D; Remke M; Taylor MD; Wechsler-Reya RJ
    Cancer Res; 2013 Oct; 73(20):6310-22. PubMed ID: 24067506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma.
    Vanner RJ; Remke M; Gallo M; Selvadurai HJ; Coutinho F; Lee L; Kushida M; Head R; Morrissy S; Zhu X; Aviv T; Voisin V; Clarke ID; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJ; Marra MA; Malkin D; Northcott PA; Kool M; Pfister SM; Bader G; Hochedlinger K; Korshunov A; Taylor MD; Dirks PB
    Cancer Cell; 2014 Jul; 26(1):33-47. PubMed ID: 24954133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development.
    Zhao H; Ayrault O; Zindy F; Kim JH; Roussel MF
    Genes Dev; 2008 Mar; 22(6):722-7. PubMed ID: 18347090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
    Rudin CM; Hann CL; Laterra J; Yauch RL; Callahan CA; Fu L; Holcomb T; Stinson J; Gould SE; Coleman B; LoRusso PM; Von Hoff DD; de Sauvage FJ; Low JA
    N Engl J Med; 2009 Sep; 361(12):1173-8. PubMed ID: 19726761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
    Bai AH; Milde T; Remke M; Rolli CG; Hielscher T; Cho YJ; Kool M; Northcott PA; Jugold M; Bazhin AV; Eichmüller SB; Kulozik AE; Pscherer A; Benner A; Taylor MD; Pomeroy SL; Kemkemer R; Witt O; Korshunov A; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):529-38. PubMed ID: 22134538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice.
    Lelievre V; Seksenyan A; Nobuta H; Yong WH; Chhith S; Niewiadomski P; Cohen JR; Dong H; Flores A; Liau LM; Kornblum HI; Scott MP; Waschek JA
    Dev Biol; 2008 Jan; 313(1):359-70. PubMed ID: 18036580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.